Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
571
datasets available to search
ShareScore release 0.9.0
Dataset results
571 results for “CLL”
A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL
ClinicalTrials.gov study NCT04876092. IPD Sharing: YES. Countries: 4. Publications: 0.
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
ClinicalTrials.gov study NCT01212380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused
ClinicalTrials.gov study NCT06362044. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Selenious Yeast in CLL Patients w/o Indication of Chemotherapy
ClinicalTrials.gov study NCT05136378. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
ClinicalTrials.gov study NCT05950997. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT05424822. IPD Sharing: YES. Countries: 8. Publications: 0.
A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL.
ClinicalTrials.gov study NCT04923048. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Activity of SNX-5422 Plus Ibrutinib in CLL
ClinicalTrials.gov study NCT02914327. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
ClinicalTrials.gov study NCT01750567. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL)
ClinicalTrials.gov study NCT01459211. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
ClinicalTrials.gov study NCT05665374. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT03153202. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
ClinicalTrials.gov study NCT01035216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00081874. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
ClinicalTrials.gov study NCT00041288. IPD Sharing: Not stated. Countries: 2. Publications: 0.
R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL
ClinicalTrials.gov study NCT04992377. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL
ClinicalTrials.gov study NCT05478512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
ClinicalTrials.gov study NCT02269592. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL
ClinicalTrials.gov study NCT03060850. IPD Sharing: NO. Countries: 1. Publications: 0.
B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression
ClinicalTrials.gov study NCT01030913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.